Table 4.
Variable | Time from Transplantation at the Start of the Study | |||
---|---|---|---|---|
1–6 Years (n = 49) | 7–22 Years (n = 60) | |||
uNGAL | uNGAL/Cr | uNGAL | uNGAL/Cr | |
Final/baseline eGFR | R = −0.28; p = 0.06 | R = −0.27; p = 0.07 | R = −0.34; p = 0.008 | R = −0.36; p = 0.007 |
Final–baseline eGFR | R = −0.34; p = 0.023 | R = −0.29; p = 0.05 | R = −0.31; p = 0.020 | R = −0.31; p = 0.019 |
eGFR based on mean creatinine during follow-up | R = −0.08; p = 0.6 | R = −0.06; p = 0.7 | R = −0.29; p = 0.029 | R = −0.35; p = 0.007 |